ZYUS: Funding, Investors & Team (Sep 2026)
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based medical solutions. The company aims to promote the use of cannabinoids as a way to alleviate discomfort caused by chronic illness, treatment side effects, or age-related conditions. Its goal is to shift the focus from treating physical disease to taking care of overall well-being by promoting the adoption of plant-based medicine. Through the use of science, ZYUS is working to establish plant-based medicine as a standard of care for disease treatment and management. Established in 2018, ZYUS is based in Saskatoon, Saskatchewan.
ZYUS has raised $26.0M across 7 funding rounds on record, the most recent an undisclosed round of $190k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ZYUS Company Profile and Key Stats
Latest funding round on record: May 2026.
ZYUS Funding Rounds
ZYUS raised $20.1M in an undisclosed round announced in Jun 2023.
6 months later, an undisclosed round of $750k was announced in Dec 2023.
8 months later, an undisclosed round of $3.3M was announced in Aug 2024.
10 months later, an undisclosed round of $180k was announced in Jun 2025.
4 months later, an undisclosed round of $1.1M was announced in Oct 2025.
5 months later, an undisclosed round of $370k was announced in Mar 2026.
2 months later, an undisclosed round of $190k was announced in May 2026.
ZYUS Founders and Leadership Team
Contact details for the ZYUS team: 1 of 4 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →ZYUS Funding Compared to Other Biotechnology Startups
ZYUS' latest round of $190k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ZYUS in Biotechnology and Saskatoon
Companies Similar to ZYUS
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
ZYUS Funding FAQs
What does ZYUS do?
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based medical solutions. The company aims to promote the use of cannabinoids as a way to alleviate discomfort caused by chronic illness, treatment side effects, or age-related conditions. Its goal is to shift the focus from treating physical disease to taking care of overall well-being by promoting the adoption of plant-based medicine. Through the use of science, ZYUS is working to establish plant-based medicine as a standard of care for disease treatment and management. Established in 2018, ZYUS is based in Saskatoon, Saskatchewan.
How much funding has ZYUS raised?
ZYUS has raised $26.0M across 7 rounds on record. The most recent is an undisclosed round of $190k announced in May 2026.
When did ZYUS last raise funding?
ZYUS' most recent funding round on record is an undisclosed round of $190k, announced in May 2026.
Who founded ZYUS?
FundedIQ lists Brent Zettl (Founder), Punit Patel (Founder), Scott W Livingstone (Founder), Smitha Sukumaran (Founder) at ZYUS.
Where is ZYUS headquartered?
ZYUS is based in Saskatoon, Saskatchewan, Canada.
How many employees does ZYUS have?
ZYUS is in the 51-100 employee band.
How does ZYUS' funding compare to other Biotechnology startups?
ZYUS' latest round of $190k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ZYUS Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ZYUS is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.